Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02742636
Other study ID # P15.382
Secondary ID
Status Completed
Phase N/A
First received April 1, 2016
Last updated August 22, 2017
Start date May 31, 2016
Est. completion date June 21, 2017

Study information

Verified date August 2017
Source Leiden University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: The aim of this study is to evaluate if direct removal of the urine catheter after an laparoscopic hysterectomy (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery, which is the current treatment. In addition, we want to investigate patient's experience on this subject.

Study design: Randomized Controlled trial, non-inferiority study.

Study population: Women older than 18 years old, who are a laparoscopic hysterectomy for benign indication or low-grade malignancy.

Intervention:

- Group A (treatment group): the patients in this group will have their catheter directly removed in the OR after LH.

- Group B (control group): the patients in the control group will have their catheter removed according to the regular protocol of the hospital (at least 6 hours in place).


Recruitment information / eligibility

Status Completed
Enrollment 162
Est. completion date June 21, 2017
Est. primary completion date June 21, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Older than 18 years

- Scheduled for LH for benign indication or low-grade malignancy (with or without salpingo-oophorectomy)

Exclusion Criteria:

- Concomitant procedures such as prolapse surgery, severe endometrioses and/or bowel resection

- Preoperative known urinary voiding problems (incontinence)

- Preoperative known urinary tract infection

- Patients suffering from diseases potentially associated with inability to void (e.g. MS)

- A Gravid or postpartum hysterectomy

Study Design


Intervention

Device:
Foley catheter
The aim of this study is to evaluate if direct removal of the urine catheter after an LH (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery.

Locations

Country Name City State
Netherlands Reinier de Graaf Groep Delft
Netherlands Groene Hart Ziekenhuis Gouda
Netherlands Alrijne Hospital Leiden
Netherlands Leiden University Medical Center Leiden Noord-Holland
Netherlands Bronovo Hospital The Hague
Netherlands Haga Hospital the Hague
Netherlands Medisch Centrum Haaglanden the Hague

Sponsors (7)

Lead Sponsor Collaborator
Leiden University Medical Center Alrijne Hospital, Bronovo Hospital, Groene Hart Ziekenhuis, Haga Hospital, Medical Center Haaglanden, Reinier de Graaf Groep

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urinary retention (inability to void) 6 hours after removal of urinary catheter
Secondary Rate of re-catheterisation 6 hours without voiding
Secondary Urinary tract infection (by performing a urine dipstick test and based on clinical symptoms) Dipstick: first urine after removal of catheter (group 1: direct after OR, group 2: at least 6 hours after OR), clinical symptoms through study period (up to 6 weeks postoperative)
Secondary Patient satisfaction (self-administrated questionnaire) 6 hours postoperative; 24 hours and 6 weeks
Secondary Visual analogue scale score (VAS score) 6 hours postoperative; 24 hours
See also
  Status Clinical Trial Phase
Completed NCT03235947 - Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients Phase 4
Terminated NCT02198833 - Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection N/A
Withdrawn NCT01881165 - Cranberry on Urinary Tract Infections Phase 4
Completed NCT02357758 - Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Phase 4
Completed NCT01687114 - Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products N/A
Completed NCT01391793 - Corticosteroids for Children With Febrile Urinary Tract Infections Phase 3
Completed NCT01219595 - Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women N/A
Completed NCT00365430 - SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes N/A
Recruiting NCT04502095 - Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy Phase 4
Completed NCT00976963 - Single Dose Monurol for Treatment of Acute Cystitis N/A
Recruiting NCT02568800 - Prolonged Infusion Cefepime and Nosocomial Infections Phase 3
Completed NCT02785445 - Healthy.io Method Comparison & User Performance Study N/A
Completed NCT02216253 - L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection. N/A
Completed NCT01478620 - Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI) Phase 3
Completed NCT01054690 - Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI) N/A
Completed NCT00371631 - Colonizing Neurogenic Bladders With Benign Flora Phase 1
Terminated NCT03697993 - Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS) Phase 4
Terminated NCT01803919 - Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients N/A
Enrolling by invitation NCT01231737 - Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin) Phase 2
Completed NCT01763008 - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections Phase 4